MiniMed Group, Inc. (B8S)
FSX
Real-time Data
06:00 AM
Day's Range
16.7552 wk Range
9.04Overview - B8S - MiniMed Group, Inc.
Key Statistics
Valuation
Enterprise Value
4.21B
P/E (Trailing)
‪-13.61‬
Price / Sales (TTM)
‪1.55‬
Price / Book
‪1.57‬
EV / EBITDA
‪16.79‬
Profitability
Gross Margin
‪55.16%‬
Profit Margin
‪-9.74%‬
Operating Margin
‪0.47%‬
Return on Assets
‪-7.19%‬
Return on Equity
‪-8.66%‬
Ownership
Shares Outstanding
281.20M
Float
28.46M
Held by Insiders
‪89.92%‬
Held by Institutions
‪13.54%‬
Price stats
50-Day Avg
‪17.21‬
200-Day Avg
‪13.83‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - B8S - MiniMed Group, Inc.
Peers - B8S - MiniMed Group, Inc.
Peer Comparison
Compared with companies in Health Information Services listed on FSX.
- B8SFSXMiniMed Group, Inc.4.97BMarket Cap+8.85%52-week change-13.62P/E (Trailing)‪-9.74%‬Profit Margin
- VEEFSXVeeva Systems Inc.42.44BMarket Cap-0.41%52-week change64.32P/E (Trailing)‪29.34%‬Profit Margin
- NXGFSXNext plc19.30BMarket Cap+13.85%52-week change18.69P/E (Trailing)‪12.89%‬Profit Margin
- CGMFSXCapgemini SE17.26BMarket Cap-15.29%52-week change13.21P/E (Trailing)‪5.86%‬Profit Margin
- F3MFSXTempus AI Inc Class A Common Stock12.98BMarket Cap+5.50%52-week change32.53P/E (Trailing)‪-17.76%‬Profit Margin
- PMCFSXPro Medicus Limited10.31BMarket Cap-77.78%52-week change62.54P/E (Trailing)‪101.39%‬Profit Margin
- 1KJFSX10x Genomics Inc. Class A Common Stock9.62BMarket Cap+86.72%52-week change-211.11P/E (Trailing)‪-12.17%‬Profit Margin
Profile Summary - B8S - MiniMed Group, Inc.
About
MiniMed Group, Inc. is a medical technology company focused on diabetes management. MiniMed develops, manufactures, and markets a connected ecosystem of products and services that includes insulin pumps, continuous glucose monitors, smart insulin pens, consumables, and supporting software. Its offerings are designed…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
